422 search results for “cognitive behaviour therapy” in the Staff website
-
300 million euros for new international stem cell consortium
The Leiden University Medical Center (LUMC), the Danstem Institute from the University of Copenhagen and the Murdoch Children’s Research Institute in Melbourne have received 300m euros from the Novo Nordisk foundation. The aim of this new international consortium is to bring stem-cell based therapies…
-
LUMC receives tens of millions for research into new stem cell-based treatments
Leiden University Medical Center (LUMC), as a partner in the reNEW consortium, is once again receiving tens of millions of euros for research into new treatments based on stem cells. The collaboration will receive a total of €150 million to develop new therapies in regenerative medicine.
-
Sofie Rasmussena.s.b.rasmussen@cml.leidenuniv.nl | 071 5272727
-
Hans Slabbekoornh.w.slabbekoorn@biology.leidenuniv.nl | 071 5275049
-
Leiden University celebrates curiosity at 449th Dies Natalis
How has evolution shaped our curiosity? And how does that curiosity ensure that we now have the technological ability to discover whether we are alone in the universe? This was all covered during the celebration of Leiden University’s 449th Dies Natalis.
-
Curing diseases with lab-grown organs
Organs and tissues grown in the lab may in the future be able to cure people with organ failures. Micha Drukker, professor of Stem Cells, Developmental Biology and Technology for Innovative Drug Research, is convinced that the use of stem cells will make this possible. He will deliver his inaugural…
-
€10.6 million for innovative toolboxes to tackle brain cancer
Researchers at the Universities of Amsterdam (Uva) and Leiden together with the Netherlands Cancer Institute and Oncode Institute have received a €10,6 million ERC Synergy Grant to develop innovative therapeutic approaches to target glioblastoma. This is a deadly primary brain tumour for which no curing…
-
Why arteriosclerosis looks like an autoimmune disease
Arteriosclerosis bears great similarities to autoimmune diseases. Researchers from Leiden University show this in a new study they published in the renowned scientific journal Nature Cardiovascular Research. 'This discovery suggests that treatment methods for autoimmune diseases might also be effective…
-
Review paper on the potential impact drug-metabolizing enzymes on brain exposure
PhD candidate Mengxu Zhang (Division of Systems Pharmacology and Pharmacy) published a comprehensive and important review on “The potential impact of CYP and UGT drug-metabolizing enzymes on brain target site drug exposure” in Drug Metabolism Reviews.
-
ULLA workshop 2023 Leiden
This week, we are hosting the ULLA workshop 2023. We are proud partner of the ULLA. It is the European University Consortium for Pharmaceutical Sciences in which LACDR participates for already 30 years.
-
In memoriam: Andrea Evers (1967 - 2025)
It is with deep sorrow that we share the news that our dear colleague Andrea Evers passed away on Monday, 4 August 2025. Since 2013, Andrea had been affiliated with the Faculty of Social and Behavioural Sciences at Leiden University as Professor of Health Psychology. She was an undeniable driving force…
-
People with Parkinson’s positive about digital at-home tests
Can cognitive decline in people with Parkinson’s disease be measured using digital tests at home? According to an interdisciplinary team of researchers, the answer is yes. They investigated this with a Kiem grant from Leiden University.
-
Chemistry as the key to medical innovation
Is it a coincidence that three chemists from the same department have each independently received a ZonMw grant? 'No,' the researchers agree in unison. 'The role of chemistry in medical biology is becoming increasingly important, and we’ve worked hard to make this happen.'
-
Vivian Kraaij
Faculty of Social and Behavioural Sciences
kraaij@fsw.leidenuniv.nl | 071 5273736
-
Nadia GarnefskiFaculty of Social and Behavioural Sciences
garnefski@fsw.leidenuniv.nl | 071 5273774
-
New platform to accelerate cardiac drug development
Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to develop a new platform that enables the automated production of 3D cardiac microtissues. This platform will allow large numbers of drugs to be tested quickly
-
New potential cancer drugs and where to find them
Cancer research generates massive amounts of data, but traditional tools often fail to fully harness their potential. How can we unlock this data to provide better treatments for cancer patients? PhD candidate Marina Gorostiola González explored this by using advanced data analysis techniques to guide…
-
Vidi grants for 12 researchers from Leiden University
An impressive 12 researchers from Leiden University have been awarded an 800,000-euro grant by the Dutch Research Council (NWO). This will enable them to develop their own line of research over the next five years.
-
Fighting gliobastoma brain tumours with two grants
Few researchers see potential in research on glioblastoma, an incurable brain tumour. Alexander Kros brought together colleagues who are up to the challenge. European research funder ERC recently made 10.6 million euros available, a year earlier NWO provided 3 million euros. ‘In six years, we certainly…
-
Olaf Dekkerso.m.dekkers@lumc.nl | 071 5269111
-
Adam Cohena.f.cohen@lumc.nl | 071 5269111
-
Henk-Jan Guchelaarh.j.guchelaar@lumc.nl | 071 5262790
-
Christi van Asperenc.j.van_asperen@lumc.nl | 071 5266090
-
Jelle Goemanj.j.goeman@lumc.nl | 071 5269700
-
Peter Devileep.devilee@lumc.nl | 071 5269510
-
Saskia le Cessies.le_cessie@lumc.nl | 071 5272124
-
Thijs van Oschm.j.p.van_osch@lumc.nl | 071 5269111
-
Carien Creutzbergc.l.creutzberg@lumc.nl | 071 5265120
-
Ferry Ossendorpf.a.ossendorp@lumc.nl | 071 5263800
-
Sjoerd van der Burgs.h.van_der_burg@lumc.nl | 071 5261180
-
Ingrid Meulenbelti.meulenbelt@lumc.nl | 071 5269734
-
Marcel Tijstermanm.tijsterman@lumc.nl | 071 5269111
-
Jacques van Dongenj.j.m.van_dongen@lumc.nl |
-
Rob Tollenaarr.a.e.m.tollenaar@lumc.nl | 071 5264910
-
Maartje SchoorlFaculty of Social and Behavioural Sciences
m.schoorl@fsw.leidenuniv.nl | 071 5274083
-
Pieter Hiemstrap.s.hiemstra@lumc.nl | 071 5269111
-
Martine Jagerm.j.jager@lumc.nl | 071 5269111
-
Ed Kuijpere.j.kuijper@lumc.nl |
-
Energy as a weak spot: a new approach to tackle aggressive breast cancer?
Could we stop cancer cells by cutting off their energy supply? That’s what Dione Blok, a bachelor’s student in Bio-Pharmaceutical Sciences, aimed to find out during her thesis research. She investigated a compound that affects the tumour cells’ energy metabolism. ‘Hopefully, these insights will provide…
-
King of Sweden visits Leiden University
Collaborating in drug discovery and health research was the goal of a visit to the Leiden Bio Science Park on 14 May by a Swedish delegation including His Majesty King Carl XVI Gustav of Sweden. The delegation visited Leiden University’s Faculty of Science.
-
A unique defence: Bacteria lose cell wall in the presence of virus
Bacteria temporarily live without their cell wall if dangerous viruses are near. A remarkable feature, as the cell wall is a sturdy barrier against threats. Still, the discovery has a logical explanation ánd might be of a consequence for fighting pathogenic bacteria, according to Véronique Ongenae,…
-
Promising new technique to treat cancer receives NWO grant
Biological chemist Nathaniel Martin and his team received an NWO grant to examine how blocking a specific enzyme in our body, NNMT, could be helpful in the treatment of some cancers. Trials with mice have been promising, and together with the Netherlands Cancer Institute, Martin wants to take the next…
-
Leiden technology research receives funding from NWO and businesses
A CT scanner to treat eye cancer, energy-efficient software for the future and a test to identify male chick eggs. Three projects by researchers from Leiden University are to receive funding from research funder NWO’s Open Technology programme, to which the business sector also contributes.
-
Better understanding of cancer drugs – Leiden spin-off Omivera receives seed investment
How do you know if a drug will actually work? The Leiden-based spin-off Omivera is developing a new technology that could provide clearer answers. The young company received a seed investment from the investment fund UNIIQ to support its development.
-
How Leiden University is taking action against cancer
One in two people will be diagnosed with cancer. World Cancer Day on 4 February raises awareness of the impact of this devastating disease. Leiden University is conducting various studies aimed at preventing and controlling cancer. Below are just a few examples.
- Blue Monday? Join the online Body & Mind Vital programme for free
-
Ilze Bot appointed professor of Cardiovascular Pharmacology
Dr Ilze Bot (LACDR) has been appointed professor of Cardiovascular Pharmacology with effect from 1 March. A recognition of her work as a scientist. 'This allows me to continue and expand my line of research within the LACDR and Leiden University.'
-
Projects 2023-2024
In 2023-2024 seven (teams of) teachers received a Grassroots or Grass shoots grant. Here you can read about their projects.
-
Thirteen NWO Open Competition XS grants for Leiden researchers
From medicines from snake venom to supercrops and the origin of words. Thirteen researchers from Leiden University will receive Open Competition XS grants from the Dutch Research Council (NWO).
-
Fourteen Leiden University researchers receive Vidi grant
The Dutch Research Council (NWO) has awarded Vidi grants to 14 Leiden researchers. This grant of a maximum of 850,000 euros will enable them to start a new research group and develop their own line of research over the next five years.